Navigation Links
Clinical Results From EntreMed's Panzem NCD and Taxol Breast Cancer,Study Presented at ASCO

ls; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).

    CONTACT:

    Ginny Dunn

    Associate Director, Corporate Communications & Investor Relations

    EntreMed, Inc.

    240.864.2643

CONTACT: Ginny Dunn, Associate Director, Corporate Communications &Investor Relations, EntreMed, Inc., +1-240-864-2643

Web site: http://www.entremed.com//

Ticker Symbol: (NASDAQ-NMS:ENMD)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

Post Your Comments:
(Date:11/26/2009)...URG, South Africa, Nov. 26 The 200... Year Award in the Generic Pharmaceutical Market i...,, (Logo: http://www.newscom.com/cgi-bin/prnh/...r Award, the following criteria were used to bench...itors: growth strategy and implementation, degree ...
(Date:11/25/2009)...Colo., Nov. 25 Heska Cor... advanced diagnostic and specialty products to t... with Roche Diagnostics Corporation for the supply...for the veterinary market. ,, (Logo: http:...) ,, "Heska and Roche share the same passion fo...
(Date:11/25/2009)...PHIA, Nov. 25 ERT (Nasda...Kelvey, the Company,s President and CEO, and Keith...nd CFO, are scheduled to present at the 21st Annua...EST on December 1, 2009 in New York City, New York...tion by visiting the Company,s corporate website a...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 1UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 2Master regulator found for regenerating nerve fibers in live animals 10511 1Master regulator found for regenerating nerve fibers in live animals 10511 2Is Smoking Tougher on Women 3F 60033 1Is Smoking Tougher on Women 3F 60033 2Is Smoking Tougher on Women 3F 60033 3
(Date:11/27/2009)...rm Replikins Ltd. today issued its latest biochemi...hows that the lethality of the virus has dropped f...current outbreak in the spring of 2009 to resting ...he H1N1 infectivity count, however, remains increa...ember 27, 2009 -- Biotech firm Replikins Ltd., whi...
(Date:11/27/2009)...nce, Nov. 27 Team Garmin-Slipstrea...dicated to ethical sporting and developing the nex... that it will become Team Garmin-Transitions with ...or of the team. Transitions Optical is the world,s...g the most advanced photochromic technology in the...
(Date:11/27/2009)... medical, economic burdens, study predicts , ...ber of people with diabetes in the United States i... study predicts. , That would bring the total b...se, up from 23.7 million today. , , At the same ...ll triple, the study also warns, rising from an es...
(Date:11/27/2009)... manufacturers who use medical load cells at the h...ars by bringing in technology partner Flintec earl...-active medical manufacturers are calling in Flint... projects, ensuring that progress will not be cons...y outdated technology. , ...
(Date:11/26/2009)...f Americans living with diabetes will nearly doubl...llion in 2034. Over the same period, spending on d...on to $336 billion, even with no increase in the p...versity of Chicago report in the December issue of...betes covered by Medicare will rise from 8.2 milli...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...l disease chikungunya is causing concern as over 1...ross nine states. Though Delhi has 28 suspect...is Karnataka with over 756,028 suspected cases and... last year when we conducted surveys in Andhra Pra...
...e food and drug watchdog, The FDA, to spruce up it.... This has been put forth vociferously by Editors ...advisory panel. A report enabled by The Inst... research of drugs as well as alter labels and war...
...Fill i.v.?, a high-speed robotic system for the pr...ed today that Children’s Medical Center Dallas has...llion syringes using the IntelliFill i.v. system. ... robotic system. “Patient safety is and alway...
...the Government must make changes to its mental hea...eting the needs of people with mental illness. ...he Prime Minister, and the AMA welcomes the Govern...rists and psychologists in team-based care, there ...
...led with serious flaws according to federal invest... medical information//. The New York Times repor...financial data on beneficiaries connecting the dat... and other private institutions. A report fro...
...es that assist in puffing out the smoking habit, h...used in combination with a nicotine patch and coun...t smoking. The medication in question, naltr...offset weight gain, which is a common occurrence w...
Other Medicine News:Health News:Medical Center Tops 3 Million IV Syringes Using IntelliFill i.v. Robotics 2Health News:Mental Health Package Regrettably Undervalues the Role of the GP 2
...represents the most widely accepted "table fixed" ...action components provides numerous surgical speci...al exposure of the surgical field. Individual BOOK...dures: IMA Kit / Bariatric Kit / SpinalKit / Small...
Rad-57
... of gene expression and melting curve-based mutati...ines amazing speed with exceptional accuracy and w...applications in genomics research including array ...is. ,This system supports all current probe f...
... the VM500, for critical temperature monitoring, l...ezers. This is a stand alone product, no computer ...ution you can stack the VM500's and monitor up to ...ilt in synthesized voice module to allow you to he...
Medicine Products: